Verified Nov 2026
Other
·

Garching, Bavaria
·
Since 2004
ITM Isotope Technologies Munich is a privately held biotechnology company founded in 2004 and headquartered in Garching, Bavaria. With 500–1,000 employees and estimated revenue of $10–50 million, it specializes in radiopharmaceuticals and theranostics for precision oncology. The company manufactures medical radioisotopes and develops targeted cancer therapeutics, operating facilities in Germany and the USA to serve healthcare partners and clinicians globally.
ITM Isotopen Technologien München AG at a glance
Revenue
$10-50M
Est. band
Employees
500-1,000
Founded
2004
Headquarters
Garching, Bavaria
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
ITM Isotope Technologies Munich is a privately held biotechnology company founded in 2004 and headquartered in Garching, Bavaria. With 500–1,000 employees and estimated revenue of $10–50 million, it specializes in radiopharmaceuticals and theranostics for precision oncology. The company manufactures medical radioisotopes and develops targeted cancer therapeutics, operating facilities in Germany and the USA to serve healthcare partners and clinicians globally.
At a glance
Attribute | Detail |
|---|---|
Founded | 2004 |
Headquarters | Garching, Bavaria |
Employees | 500-1,000 |
Revenue | $10-50M (estimated) |
What ITM Isotopen Technologien München AG makes
ITM operates a vertically integrated model combining radioisotope manufacturing with drug development, producing lutetium-177 and actinium-225 for targeted radionuclide therapies and nuclear medicine diagnostics.
Latest developments
2026-09-20 — ITM Radiopharma– Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse (itm-radiopharma.com)
2026-09-08 — ITM Radiopharma– ITM and SpiroChem Announce Strategic Discovery Collaboration to Expand ITM’s Radiopharmaceutical Pipeline (itm-radiopharma.com)
2026-08-20 — ITM Radiopharma– Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Development of AKIR001 for the Treatment of Solid Tumors (itm-radiopharma.com)
2026-06-12 — ITM Radiopharma– ITM Announces Transfer of Non-dilutive Debt Financing from Blue Owl Managed Funds to Perceptive Advisors (itm-radiopharma.com)
2026-04-17 — ITM in Discussions on Potential Sale of Its Medical Isotope Production Business - Bloomberg (bloomberg.com)
2025-09-24 — ITM Radiopharma– ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161 (itm-radiopharma.com)
Company details
The company is privately held and has completed Phase 3 trials for its lead candidate ITM-11 in preparation for commercialization. ITM Isotopen Technologien München AG was founded in 2004, has an estimated 500-1,000 employees, and is headquartered in Garching, Bavaria.
Frequently asked questions
What does ITM Isotopen Technologien München AG do?
ITM Isotope Technologies Munich is a privately held biotechnology company founded in 2004 and headquartered in Garching, Bavaria. With 500–1,000 employees and estimated revenue of $10–50 million, it specializes in radiopharmaceuticals and theranostics for precision oncology. The company manufactures medical radioisotopes and develops targeted cancer therapeutics, operating facilities in Germany and the USA to serve healthcare partners and clinicians globally.
Where is ITM Isotopen Technologien München AG headquartered?
ITM Isotopen Technologien München AG is headquartered in Garching, Bavaria.
When was ITM Isotopen Technologien München AG founded?
ITM Isotopen Technologien München AG was founded in 2004.
How big is ITM Isotopen Technologien München AG?
ITM Isotopen Technologien München AG has an estimated 500-1,000 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
